Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer: A Phase II Randomized Controlled Trial

NCT07171528 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.

NCT NCT07171528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07171528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer: A Phase II Randomized Controlled Trial
Lead sponsor
National Cancer Center, Korea
Phase
Phase 2
Overall status
Recruiting
Start date
September 10, 2025
Completion date
December 31, 2033
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer